<DOC>
<DOCNO>
EP-0010294
</DOCNO>
<TEXT>
<DATE>
19800430
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/175 C07C-239/00 C07D-265/00 A61K-31/395 C07D-295/00 A61K-31/17 <main>C07C-133/00</main> C07D-295/22 C07D-295/28 C07C-291/02 C07D-265/30 C07C-291/00 C07C-67/00 A61P-35/00 
</IPC-CLASSIFICATIONS>
<TITLE>
1-(2-haloethyl)-1-nitroso ureas and their preparation.
</TITLE>
<APPLICANT>
deutsches krebsforschde<sep>stiftung deutsches krebsforschungszentrum<sep>stiftung deutsches krebsforschungszentrumim neuenheimer feld 280d-6900 heidelberg 1de<sep>stiftung deutsches krebsforschungszentrum<sep>
</APPLICANT>
<INVENTOR>
eisenbrand gerhard dr<sep>eisenbrand, gerhard, dr.<sep>eisenbrand, gerhard, dr.banngartenstrasse 19d-6902 sandhausende<sep>eisenbrand, gerhard, dr.<sep>eisenbrand, gerhard, dr.banngartenstrasse 19d-6902 sandhausende<sep>
</INVENTOR>
<ABSTRACT>
1,3-disubstituted nitrosohears of the general formula wherein R₁ and R₂ are straight or branched chain alkyl, which may also be substituted with up to 3 radicals OH, COOH, COOR or CONH₂, wherein R is an alkyl group having 1 to 6 cohesome atoms, or wherein R₁ and R₂ may be constituents of a saturated or unsaturated ring system, in particular a 6-membered ring system, which may also contain further heteroatoms, in particular oxygen or nitrogen, and wherein the ring additionally with up to 3 group OH, COOH, Coor, wherein R has the meaning given above, conh₂, hal or with the chloroethylnitrosoureido group may be substituted and is a chlorine or fluorine, as well as methods of their manufacture by reaction of N- (2-haloethyl) -n nitrosocarbamoylazide with a hydra zinder derivative or a cyclic N-amino compound. The mentioned urea derivatives have tumor-inhibiting we kung.
</ABSTRACT>
</TEXT>
</DOC>
